Support for a TAVR-first approach in patients with concurrent valve and coronary disease
New research indicates feasibility and helps identify which patients could benefit
Lower success rates, more hospital MACE seen with poor-quality distal targets
Metabolite proves predictive in a large prospective cohort of apparently healthy subjects
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Measuring residual risk of adverse perivascular adipose tissue remodeling
It’s safe and accurate, but who should be tested?
Insights on the practical application and limitations of a common test
Perivascular fat attenuation index could transform primary and secondary prevention
Sorting out pros and cons of various imaging studies
‘A gateway to...a new range of therapies for atherosclerosis’